SANCO prenatal test

Material: Blood
Test price: PLN 2,200
Waiting time for results: result after 7 working days
Reservation:

  • Advance booking required by calling 81 532 37 11.

Preparation for the examination

General

  • The material for testing is blood.
  • The patient does not need to fast.

Specific for women

  • The test can be performed on women between 10 and 24 weeks of pregnancy, both
    singleton and twin pregnancies, as well as in the case of in vitro fertilization (IVF).

Description

The SANCO test is a non-invasive prenatal test that allows you to assess the risk of trisomy by analyzing cell-free DNA from maternal blood.
Genetic diagnosis is performed directly on fetal DNA, resulting in the highest accuracy rate of over 99%.
Advantages and benefits of the SANCO test
: • Only 10 ml of maternal peripheral blood is needed to perform the test.
• There is no risk of intrauterine infection or miscarriage.
• High accuracy and effectiveness. This test has a sensitivity of over 99.9% for Down syndrome, Patau syndrome, and Edwards syndrome.
• Quick and timely.
The test can be ordered by a gynecologist during a gynecological visit for women between 10 and 24 weeks of pregnancy.
It is intended for patients with singleton or twin pregnancies resulting from natural conception or in vitro fertilization (IVF).
The waiting time for results is approximately 7 business days.
Indications:
• Women over 35 years of age who do not wish to undergo invasive prenatal testing.
• Women whose biochemical and ultrasound results in the first and second trimesters of pregnancy suggest a high risk
of chromosomal aneuploidies.
• Women who wish to undergo non-invasive testing for trisomy 21, 18, and 13, the baby's gender can also be determined.
• Women who have contraindications to invasive prenatal testing, such as placenta praevia, high risk of miscarriage,
HBV, HIV infection, etc.
• Women who have undergone in vitro fertilization.
Contraindications to the test
: • If the patient has cancer.
• If the patient has experienced twin demise in a multiple pregnancy after the 8th week of pregnancy. • If
the patient has systemic lupus erythematosus.
• If the woman has ever undergone stem cell therapy.
• If the woman has undergone a blood transfusion within 3 months before conception.
• If the woman has undergone an organ or bone marrow transplant.

Preparation and development of material (applies only to contractors)

Enter one-time code: Show